Aemetis Biogas Receives CARB Approval for Six Dairy RNG Pathways

Aemetis secures CARB approval for six new dairy digesters, expanding LCFS credit generation.

What the company is saying

Aemetis, Inc. announces that the California Air Resources Board has approved provisional LCFS pathways for six dairy digesters operated by its subsidiary, Aemetis Biogas LLC, effective October 1, 2026. The company frames this as a major operational milestone, emphasizing that these approvals, combined with seven pathways approved in June 2025, will significantly increase the number of LCFS credits generated by its Central Digester Project. Eric McAfee, Chairman and CEO, highlights that two more digesters recently built are expected to receive pathway approvals next year, using the Tier 1 filing process. The narrative stresses expectations of large reductions in excess banked LCFS credits and forecasts that the current $90 market price for LCFS credits will continue to rise. Operational scale is underscored by citing 14 digesters supplied by 17 dairies, a 36-mile pipeline, and a central renewable natural gas facility interconnected with PG&E. The company also details its 65 million gallon per year ethanol plant in California and an 80 million gallon per year biodiesel facility in India, with additional projects in sustainable aviation fuel and CO2 sequestration under development. The tone is confident and forward-looking, with claims of significant impact but limited quantification.

What the data suggests

The announcement confirms regulatory approval for six new LCFS pathways, effective October 1, 2026, with an average carbon intensity of negative 351 for these pathways. This brings the total to 13 approved dairy digesters, after seven were approved in June 2025. The Aemetis Biogas Central Digester Project now comprises 14 digesters processing waste from 17 dairies, with biogas transported via a 36-mile pipeline to a central facility. The company operates a 65 million gallon per year ethanol plant in California supplying about 80 dairies, and an 80 million gallon per year biodiesel plant in India. The current market price for LCFS credits is cited at $90, but no figures are given for the volume of credits generated, revenue impact, or financial performance. Claims of significant increases in LCFS credits and expectations of price rises are not quantified or supported by data. The operational disclosures are specific, but the financial implications remain unsubstantiated.

Analysis

The announcement is positive in tone and highlights a concrete regulatory milestone: CARB approval for six new LCFS pathways, effective October 1, 2026, with specific operational details (number of digesters, carbon intensity, pipeline length, and production capacities). However, several key claims are forward-looking, including expectations for additional pathway approvals, reductions in excess LCFS credits, and future LCFS credit price increases. The company also references ongoing development of capital-intensive projects (sustainable aviation fuel plant, CO2 sequestration) without providing timelines, investment amounts, or financial impact. No profitability, revenue, or cash flow metrics are disclosed, so the financial benefit of these operational milestones cannot be assessed. The language around 'significant increases' in LCFS credits and 'large reductions' in excess credits is not quantified. The gap between narrative and evidence is moderate: operational progress is real, but financial and future benefit claims are unsubstantiated.

Risk flags

• ●The announcement does not disclose the actual number of LCFS credits generated or the incremental financial impact from the new pathway approvals, making it difficult to assess the true economic benefit. Without these figures, investor visibility into revenue growth and profitability is limited.
• ●Several forward-looking statements, such as expectations for continued LCFS credit price increases and large reductions in excess banked credits, are speculative and unsupported by market data or historical trends. This introduces uncertainty around the sustainability and scale of future financial gains.
• ●The company references ongoing capital-intensive projects—such as a sustainable aviation fuel plant and a CO2 sequestration project—without providing timelines, investment requirements, or progress milestones. This lack of detail increases execution risk and makes it challenging to evaluate the potential impact or capital needs.

Bottom line

Aemetis has achieved a tangible regulatory milestone with CARB's approval of six new LCFS pathways, expanding its biogas operations and potential to generate LCFS credits at a time when the market price is $90 per credit. The operational footprint is significant, with 14 digesters, a 36-mile pipeline, and large-scale ethanol and biodiesel production facilities in California and India. However, the company does not disclose how many LCFS credits it will generate, what the revenue impact will be, or how these approvals translate into financial performance. Forward-looking statements about credit price increases and future project development are not backed by data or timelines. For investors, the key takeaway is that while operational scale and regulatory progress are real, the financial upside remains unquantified and subject to execution and market risks. More detailed disclosure on LCFS credit generation volumes and realized financial results would be needed to assess the true value of these milestones.

Announcement summary

(NASDAQ:AMTX) Aemetis, Inc. announced that the California Air Resources Board (CARB) has approved provisional pathways under the Low Carbon Fuel Standard (LCFS) for six dairy digesters built and operated by Aemetis Biogas LLC, a subsidiary of the company. The pathway approvals are effective as of October 1, 2026. The average carbon intensity for the six approved pathways is negative 351. In June 2025, seven dairy pathways were previously approved. The approval of these six additional pathways significantly increases the number of LCFS credits generated by the Aemetis Biogas Central Digester Project. Eric McAfee, Chairman and CEO of Aemetis, stated that two additional dairy digesters recently constructed will be eligible to receive LCFS pathway approvals next year using the Tier 1 filing process. The company expects large reductions in the number of excess banked LCFS credits each quarter for many years. Aemetis expects the current $90 market price for LCFS credits to continue to increase. The Aemetis Biogas Central Digester Project near Modesto, California, currently includes 14 digesters supplied by waste from 17 dairies. The biogas is transported by 36 miles of pipeline to a central renewable natural gas production facility in Keyes, California, which is interconnected to the PG&E utility pipeline. Aemetis owns and operates a 65 million gallon per year ethanol production facility in California’s Central Valley near Modesto that supplies about 80 dairies with animal feed. The company also owns and operates an 80 million gallon per year production facility on the East Coast of India producing high-quality biodiesel and refined glycerin. Aemetis is developing a sustainable aviation fuel plant and a CO2 sequestration project in California to utilize byproducts from ethanol production.

Disagree with this article?